• No results found

[PDF] Top 20 Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy

Has 10000 "Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy" found on our website. Below are the top 20 most common "Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy".

Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy

Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy

... sensitivity measured by Humphrey visual field analyzer and morphological changes in eyes with CSC. They found a significant correlation between retinal sensitivity and height of the serous retinal detachment. It ... See full document

7

Comparing half dose photodynamic therapy with high density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial

Comparing half dose photodynamic therapy with high density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial

... CRC: Central Reading Center; CRF: case report form; CSC: central serous chorioretinopathy; cCSC: chronic central serous chorioretinopathy; DMC: data monitoring ... See full document

17

Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy

Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy

... month after treatment and remained stable at 3 months and 6 ...improved after treat- ...In chronic CSCR the photoreceptors at the areas of su- bretinal fluid may undergo dysfunction and degeneration ... See full document

6

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy

... weeks after half-dose photodynamic therapy, which was only performed in the left eye, both subretinal fluid and posterior cystoid retinal degeneration had disappeared ... See full document

10

Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy

Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy

... standard dose of verteporfin in photodynamic therapy has proven effective for the treatment of longstanding CSC and CSC with leakage at the macula, as it has resulted in subretinal fluid ... See full document

6

The relationship between foveal outer nuclear layer thickness in the active and resolved phases of central serous chorioretinopathy treated with half-dose photodynamic therapy

The relationship between foveal outer nuclear layer thickness in the active and resolved phases of central serous chorioretinopathy treated with half-dose photodynamic therapy

... The majority of CSC eyes showed some increase in the foveal ONL thickness 12 months after half-dose PDT relative to that before half-dose PDT (Table 1:9.15 ± 8.16 μm; t = 8.83, P = ... See full document

6

<p>Half-dose photodynamic therapy for serous non-neovascular retinal pigment epithelial detachment</p>

<p>Half-dose photodynamic therapy for serous non-neovascular retinal pigment epithelial detachment</p>

... of half-dose PDT, is a quantitative measure of anatomic abnormalities of the ...with central serous chorioretinopathy, the subfoveal choroid is thicker in eyes with choroidal vascular ... See full document

10

Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy

Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy

... a half-dose of verteporfin with those of a one-third dose of verteporfin for ...the half-dose photodynamic therapy group, choroidal thickness reduced significantly from ... See full document

7

Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy

Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy

... Of the eight patients included in this report, there were seven males (87.5%) and one female (12.5%) with a mean age of 46.25 ± 11.18 years (range 35–70). Three right eyes (37.5%) and five left eyes (62.5%) were treated, ... See full document

6

Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy

Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy

... of half-dose PDT in the treatment of chronic CSR at improving both functional and anatomic ...BCVA after treatment, which was noted in the early follow-up visit and sustained until the final ... See full document

5

Choroidal neovascularization emerged right from the focal choroidal excavation in eyes with central serous chorioretinopathy post half-dose photodynamic therapy: a case report

Choroidal neovascularization emerged right from the focal choroidal excavation in eyes with central serous chorioretinopathy post half-dose photodynamic therapy: a case report

... to chorioretinopathy over an observation period ...in central serous chorioretinopathy (CSC) and found that CSC with FCE is not uncommon ...[8]. Photodynamic therapy (PDT), as ... See full document

6

Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy

Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy

... This study demonstrates that using the automated static perimeter, eyes with resolved CSCR after HD-PDT, have lower retinal sensitivity in the central macula than their nor- mal fellow eyes with a ... See full document

5

Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy

Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy

... low-fluence photodynamic therapy at baseline (left column) and after therapy (right ...with central serous chorioretinopathy (top ...of therapy (top ... See full document

6

Efficacy of 1/3 Dose Verteporfin Photodynamic Therapy for Subacute Central Serous Chorioretinopathy

Efficacy of 1/3 Dose Verteporfin Photodynamic Therapy for Subacute Central Serous Chorioretinopathy

... 2003, photodynamic therapy (PDT) with full-dose verteporfin was reported as a new treatment for chronic CSC ...occur after full-dose verteporfin PDT [8] [9] [10] ...with ... See full document

9

The comparison of multimodal imaging findings of central serous chorioretinopathy patients in regard to the early anatomically treatment response to half-fluence photodynamic therapy: a retrospective case–control study

The comparison of multimodal imaging findings of central serous chorioretinopathy patients in regard to the early anatomically treatment response to half-fluence photodynamic therapy: a retrospective case–control study

... Central serous chorioretinopathy was a usually self- limited condition which in general spontaneously resolves within 4–6 months; therefore observation was preferred over treatment in the first ... See full document

8

Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy

Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy

... of evaluation at the early phase within 1–2 weeks after PDT and insufficient evaluation of retinal ...retina after PDT are therefore required both morphologically and functionally, allowing us ... See full document

8

Photodynamic therapy in combination with intravitreal ziv-aflibercept and aflibercept injection in patients with chronic or repeatedly recurrent acute central serous chorioretinopathy: a single-center retrospective study

Photodynamic therapy in combination with intravitreal ziv-aflibercept and aflibercept injection in patients with chronic or repeatedly recurrent acute central serous chorioretinopathy: a single-center retrospective study

... Statistical analysis was performed using the R program- ming language (version 3.3.3; https://www.R-project.org/). The exact sign test was used to compare ETDRS BCVA before treatment and 6 months post-PDT. The intraclass ... See full document

9

Atypical vitelliform macular dystrophy misdiagnosed as chronic central serous chorioretinopathy: case reports

Atypical vitelliform macular dystrophy misdiagnosed as chronic central serous chorioretinopathy: case reports

... VMD can develop in various age groups, is usually bi- lateral, and induces a severe decrease of vision in the early stage, but in some cases visual acuity loss pro- gresses insidiously. The typical fundus finings of VMD ... See full document

8

Visual Functions after Laser Photocoagulation in Central Serous Chorioretinopathy

Visual Functions after Laser Photocoagulation in Central Serous Chorioretinopathy

... unilateral central serous chorioretinopathy (CSC) and compare them with their non-affected eye and with a control ...years after laser treatment, there were only nonsignificant differences of ... See full document

7

High-dose antioxidants for central serous chorioretinopathy; The randomized placebo-controlled study

High-dose antioxidants for central serous chorioretinopathy; The randomized placebo-controlled study

... Central serous chorioretinopathy (CSC) is a disease that affects young patients and sometimes results in chronic maculopathy that might permanently affect visual ...months after the ... See full document

7

Show all 10000 documents...